Observational study to describe the impact of treatment combinations with Daratumumab versus other alternative regimens in patients with relapsed / refractory multiple myeloma. Spain real world evidence (RWE) data. GeminiS study.

Saved in:
Bibliographic Details
Title: Observational study to describe the impact of treatment combinations with Daratumumab versus other alternative regimens in patients with relapsed / refractory multiple myeloma. Spain real world evidence (RWE) data. GeminiS study.
Authors: Tamayo, Rafael Ríos, Herraiz, Mario Arnao, domingo garcía, abel, Sanchez-Majano Suarez-Llanos, Jose Luis, Soler, Juan Alfons, Guiñon, Antonio Garcia, Lopez, Sebastian Garzon, Guia, Ana, Farre, Carolina Leiva, Pardo, Miriam Gonzalez, Rubia, Javier DE.LA., Mateos, Maria-Victoria
Source: Clinical lymphoma, myeloma & leukemia Oct2019 Supplement; Vol. 19.
Journal Info: Publisher: Elsevier B.V. ISSN: 2152-2650
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2152-2669
DOI:10.1016/j.clml.2019.09.245